Long-Term Follow-up of the Cohort from a Study of Weight-Reduction and/or Low-Sodium Diet plus Acetazolamide vs. Diet plus Placebo in Subjects with Idiopathic Intracranial Hypertension with Mild Visual Loss


Status: Completed
Keywords: Idiopathic intracranial hypertension (IIHTT)
IRB Number: 00065329
Specialty: Ophthalmology
Sub Specialties: Neuro-Ophthalmology

Brief Summary

The primary objective is determining the long-term frequency of the various idiopathic intracranial hypertension (IIH) clinical states and the risk factors related to clinical state transitions. The secondary objectives are to determine long-term visual and quality of life outcomes in IIH and the relationships among them and to determine the long-term outcome of the IIHTT weight management program and the factors related to success and failure.

Principal Investigator: Kathleen Digre
Department: Neurology
Co Investigator:

Contact Information

Name:Barbara Hart
Phone: 801-581-6459
Email: barbara.hart@hsc.utah.edu

Inclusion Criteria

1. Subjects with IIH previously enrolled in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).

2. Gender: Males and females. Women may be pregnant or nursing. No birth control measures are required for study participation.

3. Willingness and ability to comply with study requirements.

4. Signed informed consent.

Exclusion Criteria

1. Presence of a physical, mental, or social condition likely to affect follow-up (drug addiction, terminal illness, no telephone, homeless).

2. Anticipation of a move from the site area within 6 months and unwillingness to return for follow-up at an LIIHTT study site. If feasible, subjects who move from their initial site area may be enrolled at a different NORDIC site and followed up there.